Myopia, Moderate

2

Review clinical trials related to Myopia, Moderate. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Prospective, Randomized Clinical Study of Two Phakic Toric Implantable Lenses

Primary Objective: To compare the efficacy and the residual refractive error of EYECRYLTM Phakic toric versus Visian® Toric ICL in moderate to high myopic patient with co-existing astigmatism. Secondary Objectives: To evaluate and compare the safety of EYECRYLTM Phakic toric versus Visian® Toric ICL in moderate to high myopic patients with co-existing astigmatism.

Participants needed: 172
Trial details
Age: 21+Biological sex: AllType: InterventionalSponsor: Biotech Healthcare Holding GmbhUpdated: Feb 21, 2025Locations: 4
Eligibility criteria

Patients 21 years old or older. [+10]

Subject with acute and chronic disease or illness that would increase the operat... [+13]

Status: Recruiting

Software Refraction With Mobilerone Versus Retinoscopy

Software refraction in the mobilerone for myopia and astigmatism is a novel medical device for myopia adults and elder children with or without astigmatism. And the investigators would like to test its accuracy and efficacy as well as safety.

Participants needed: 120
Trial details
Age: 10-46Biological sex: AllType: InterventionalSponsor: Beijing Airdoc Technology Co., Ltd.Updated: Sep 28, 2023Locations: 3
Eligibility criteria

• subject with ametropia on each eye ≤-12.00D [+9]

• subject with a topography showing an anomaly (keratoconus type or other) [+3]